Document is current
Any future updates will be listed below
-
Authors
Kotani, Yuki https://orcid.org/0000-0002-9532-2859
Belletti, Alessandro https://orcid.org/0000-0003-3131-0565
D’Amico, Filippo
Bonaccorso, Alessandra
Wieruszewski, Patrick M.
Fujii, Tomoko
Khanna, Ashish K.
Landoni, Giovanni
Bellomo, Rinaldo
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 8 December 2024
First Online: 30 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: YK has received consultancy fees from Viatris. PMW previously received consultant fees from Viatris. AKK received consulting fees from Medtronic, Edwards Life Sciences, Philips Research North America, Hillrom, GE Healthcare, Potrero Medical, Viatris Pharma, Trevena Pharma, Fifth Eye Inc., Pharmazz Inc., Retia Medical and Caretaker Medical. He is also funded with a Wake Forest Clinical and Translational Science Institute (CTSI) grant on renin dysfunction in septic shock. GL has received speaker fees from Medis, Paion, and Viatris and consultancy fees from Paion and Viatris. RB has received grants and consultancy fees from La Jolla Pharmaceuticals, Paion AG, and Viatris. The other authors have no competing interests.
